Interestingly, SSX2 CD4+ T cells failed to recognize IFNγ-treated melanoma cells expressing SSX2 and class II MHC molecules (HLA-DP); however, they were stimulated by antigen-loaded dendritic cells. The gene discussed is CD4; the disease is melanoma.